Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Issam Makhoul

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Bone Marrow Research|May 31, 2014
Autologous Graft versus Host Disease: An Emerging Complication in Patients with Multiple MyelomaAnu Batra, Michele Cottler-Fox, Terry Harville, et al.
Cancer Biology & Therapy|April 23, 2016
Role of EZH2 histone methyltrasferase in melanoma progression and metastasisFade Mahmoud, Bradley Shields, Issam Makhoul, et al.
Reviews on Recent Clinical Trials|February 28, 2015
Defining and managing expectations for early immunotherapy cancer trialsThomas Kieber-Emmons, Angela Pennisi, Anna Lane, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 26, 2018
Thinking CancerAnastas Pashov, Cinthia Violeta Hernandez Puente, Saddam Mohammed Ibrahim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 20, 2017
Do checkpoint inhibitors rely on gut microbiota to fight cancer?Belal Firwana, Nathan Avaritt, Bradley Shields, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast CancerValentina K Todorova, Stephanie D Byrum, Allen J Gies, et al.
Oncology Research|March 4, 2017
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsValentina K Todorova, Issam Makhoul, Ishwori Dhakal, et al.
The Permanente Journal|February 26, 2020
Immunotherapy Outcomes in Advanced Melanoma in Relation to AgeKrishna Joshi, Dinesh Atwal, Rahul Ravilla, et al.
Plos One|December 5, 2012
Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelValentina K Todorova, Marjorie L Beggs, Robert R Delongchamp, et al.
Journal of Clinical Apheresis|July 22, 2014
Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitorSoumya Pandey, Mayumi Nakagawa, Eric R Rosenbaum, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Bone Marrow Research|May 31, 2014
Autologous Graft versus Host Disease: An Emerging Complication in Patients with Multiple MyelomaAnu Batra, Michele Cottler-Fox, Terry Harville, et al.
Cancer Biology & Therapy|April 23, 2016
Role of EZH2 histone methyltrasferase in melanoma progression and metastasisFade Mahmoud, Bradley Shields, Issam Makhoul, et al.
Reviews on Recent Clinical Trials|February 28, 2015
Defining and managing expectations for early immunotherapy cancer trialsThomas Kieber-Emmons, Angela Pennisi, Anna Lane, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 26, 2018
Thinking CancerAnastas Pashov, Cinthia Violeta Hernandez Puente, Saddam Mohammed Ibrahim, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|June 20, 2017
Do checkpoint inhibitors rely on gut microbiota to fight cancer?Belal Firwana, Nathan Avaritt, Bradley Shields, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Circulating Exosomal microRNAs as Predictive Biomarkers of Neoadjuvant Chemotherapy Response in Breast CancerValentina K Todorova, Stephanie D Byrum, Allen J Gies, et al.
Oncology Research|March 4, 2017
Polymorphic Variations Associated With Doxorubicin-Induced Cardiotoxicity in Breast Cancer PatientsValentina K Todorova, Issam Makhoul, Ishwori Dhakal, et al.
The Permanente Journal|February 26, 2020
Immunotherapy Outcomes in Advanced Melanoma in Relation to AgeKrishna Joshi, Dinesh Atwal, Rahul Ravilla, et al.
Plos One|December 5, 2012
Transcriptome profiling of peripheral blood cells identifies potential biomarkers for doxorubicin cardiotoxicity in a rat modelValentina K Todorova, Marjorie L Beggs, Robert R Delongchamp, et al.
Journal of Clinical Apheresis|July 22, 2014
Rituximab and intermediate-purity plasma-derived factor VIII concentrate (Koate®) as adjuncts to therapeutic plasma exchange for thrombotic thrombocytopenic purpura in patients with an ADAMTS13 inhibitorSoumya Pandey, Mayumi Nakagawa, Eric R Rosenbaum, et al.
Pageof 9